FOLH1 and prostate cancer: The patients underwent 18F-PSMA-1007 PET/CT and they reported that the semiquantitative analysis of the primary tumor on 18F-PSMA-1007 PET/CT imaging contributes to the risk stratification of prostate cancer, while the semiquantitative variable TL-PSMAp was better to determine high-risk prostate cancer [35].